作者
Carlos Macaya, Patrick W Serruys, Peter Ruygrok, Harry Suryapranata, Gijs Mast, Silvio Klugmann, Philippe Urban, Peter den Heijer, Karel Koch, Rudiger Simon, Marie-Claude Morice, Peter Crean, Hans Bonnier, William Wijns, Nicolas Danchin, Claude Bourdonnec, Marie-Angèle Morel, Benestent Study Group
发表日期
1996/2/1
期刊
Journal of the American College of Cardiology
卷号
27
期号
2
页码范围
255-261
出版商
Elsevier
简介
Objectives
This study sought to determine the 1-year clinical follow-up of patients included in the Benestent trial.
Background
The Benestent trial is a randomized study comparing elective Palmaz-Schatz stent implantation with balloon angioplasty in patients with stable angina and a de novo coronary artery lesion. Seven-month follow-up data have shown a decreased rate of restenosis and fewer clinical events in the stent group. It is not established whether this favorable clinical outcome is maintained for longer periods or whether coronary stenting defers restenosis and its subsequent clinical manifestations.
Methods
To clarify this uncertainty, we updated clinical information on all but 1 of 516 patients enrolled in the Benestent trial (257 in balloon group, 259 in stent group) at least 12 months after the intervention. Major clinical events (primary clinical end point) were tabulated according to the intention to treat …
引用总数
学术搜索中的文章
C Macaya, PW Serruys, P Ruygrok, H Suryapranata… - Journal of the American College of Cardiology, 1996
